ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY
Clinical trials for ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids battling leukemia that Won't stay away
Disease control Recruiting nowThis study is testing a drug called tafasitamab in children with a very high-risk form of leukemia that has come back or hasn't responded to other treatments, including stem cell transplants. The goal is to see if this antibody drug is safe for kids and if it can help prevent the…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Apr 04, 2026 06:21 UTC
-
New cell therapy trial offers hope for tough blood cancers
Disease control Recruiting nowThis study is testing an experimental cell therapy called CTD402 for people aged 12 and older whose T-cell leukemia or lymphoma has come back or hasn't responded to other treatments. Participants receive a single infusion of these specially modified immune cells and are then moni…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: BIOHENG THERAPEUTICS US LLC • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC